The E&M Co., Ltd. (KOSDAQ:089230)
2,280.00
+235.00 (11.49%)
At close: Oct 8, 2026
The E&M Revenue
The E&M had revenue of 7.33B KRW in the quarter ending June 30, 2026, with 60.27% growth. This brings the company's revenue in the last twelve months to 16.77B, down -12.59% year-over-year. In the year 2025, The E&M had annual revenue of 12.34B, down -44.40%. That makes The E&M the 36,271st largest company in the world by revenue and 2,322nd in South Korea.
Revenue (ttm)
16.77B
Revenue Growth
-12.59%
P/S Ratio
5.36
Revenue / Employee
236.15M
Employees
71
Market Cap
89.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.34B | -9.86B | -44.40% |
| Dec 31, 2024 | 22.20B | -9.51B | -29.98% |
| Dec 31, 2023 | 31.70B | -14.90B | -31.97% |
| Dec 31, 2022 | 46.60B | -7.28B | -13.51% |
| Dec 31, 2021 | 53.88B | -4.74B | -8.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioSmart | 562.68B |
| SY Dong-A | 391.73B |
| TSI Co., Ltd. | 312.00B |
| JUNGDAWN | 151.50B |
| Hanil Forging Industrial | 142.78B |
| Mgame | 90.18B |
| Sinil Pharmaceutical | 86.82B |
| Polaris AI Pharma | 63.94B |